Literature DB >> 1285499

Desmin and vimentin as markers of regeneration in muscle diseases.

A Gallanti1, A Prelle, M Moggio, P Ciscato, N Checcarelli, M Sciacco, A Comini, G Scarlato.   

Abstract

Localization and distribution of desmin and vimentin have been studied in different neuromuscular disorders using monoclonal antibodies. We have demonstrated that vimentin, although virtually absent in normal human muscle fibers, is expressed in regenerating fibers in different neuromuscular disorders. Moreover, these fibers showed a strong positivity with desmin antibodies. In normal muscle fibers desmin is only localized at Z-line level. These results suggest that desmin and vimentin may be over-expressed during muscle regeneration processes, probably because of their importance in the structural organization of the sarcomere.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1285499     DOI: 10.1007/bf00304637

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  16 in total

1.  Different intermediate-sized filaments distinguished by immunofluorescence microscopy.

Authors:  W W Franke; E Schmid; M Osborn; K Weber
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

2.  Desmin and vimentin coexist at the periphery of the myofibril Z disc.

Authors:  B L Granger; E Lazarides
Journal:  Cell       Date:  1979-12       Impact factor: 41.582

3.  The distribution of intermediate filament protein (skeletin) in normal and diseased human skeletal muscle--an immunohistochemical and electron-microscopic study.

Authors:  L E Thornell; L Edström; A Eriksson; K G Henriksson; K A Angqvist
Journal:  J Neurol Sci       Date:  1980-08       Impact factor: 3.181

4.  The distribution of desmin and titin in normal and dystrophic human muscle.

Authors:  M J Cullen; J J Fulthorpe; J B Harris
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

5.  Myotubular myopathy: arrest of morphogenesis of myofibres associated with persistence of fetal vimentin and desmin. Four cases compared with fetal and neonatal muscle.

Authors:  H B Sarnat
Journal:  Can J Neurol Sci       Date:  1990-05       Impact factor: 2.104

6.  Neuromyopathy and restrictive cardiomyopathy with accumulation of intermediate filaments: a clinical, morphological and biochemical study.

Authors:  E Bertini; C Bosman; E Ricci; S Servidei; R Boldrini; M Sabatelli; G Salviati
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

7.  The synthesis and distribution of desmin and vimentin during myogenesis in vitro.

Authors:  D L Gard; E Lazarides
Journal:  Cell       Date:  1980-01       Impact factor: 41.582

8.  Distributions of vimentin and desmin in developing chick myotubes in vivo. II. Immunoelectron microscopic study.

Authors:  K T Tokuyasu; P A Maher; S J Singer
Journal:  J Cell Biol       Date:  1985-04       Impact factor: 10.539

9.  Redistribution of intermediate filament subunits during skeletal myogenesis and maturation in vitro.

Authors:  G S Bennett; S A Fellini; Y Toyama; H Holtzer
Journal:  J Cell Biol       Date:  1979-08       Impact factor: 10.539

10.  Distributions of vimentin and desmin in developing chick myotubes in vivo. I. Immunofluorescence study.

Authors:  K T Tokuyasu; P A Maher; S J Singer
Journal:  J Cell Biol       Date:  1984-06       Impact factor: 10.539

View more
  25 in total

1.  Changes in cytochemistry of sensory and nonsensory cells in gentamicin-treated cochleas.

Authors:  Shun-Ichi Imamura; Joe C Adams
Journal:  J Assoc Res Otolaryngol       Date:  2003-06

2.  Barriers in contribution of human mesenchymal stem cells to murine muscle regeneration.

Authors:  Anabel S de la Garza-Rodea; Hester Boersma; Cheryl Dambrot; Antoine Af de Vries; Dirk W van Bekkum; Shoshan Knaän-Shanzer
Journal:  World J Exp Med       Date:  2015-05-20

3.  Effect of Divalent Cations on the Structure and Mechanics of Vimentin Intermediate Filaments.

Authors:  Huayin Wu; Yinan Shen; Dianzhuo Wang; Harald Herrmann; Robert D Goldman; David A Weitz
Journal:  Biophys J       Date:  2020-05-22       Impact factor: 4.033

4.  The cardiac isoform of alpha-actin in regenerating and atrophic skeletal muscle, myopathies and rhabdomyomatous tumors: an immunohistochemical study using monoclonal antibodies.

Authors:  Roland Moll; Hans-Jürgen Holzhausen; Hans-Dieter Mennel; Caecilia Kuhn; Renate Baumann; Christiane Taege; Werner W Franke
Journal:  Virchows Arch       Date:  2006-05-20       Impact factor: 4.064

Review 5.  Overview of the Muscle Cytoskeleton.

Authors:  Christine A Henderson; Christopher G Gomez; Stefanie M Novak; Lei Mi-Mi; Carol C Gregorio
Journal:  Compr Physiol       Date:  2017-06-18       Impact factor: 9.090

6.  The role of vimentin intermediate filaments in cortical and cytoplasmic mechanics.

Authors:  Ming Guo; Allen J Ehrlicher; Saleemulla Mahammad; Hilary Fabich; Mikkel H Jensen; Jeffrey R Moore; Jeffrey J Fredberg; Robert D Goldman; David A Weitz
Journal:  Biophys J       Date:  2013-10-01       Impact factor: 4.033

7.  The expression of vimentin in satellite cells of regenerating skeletal muscle in vivo.

Authors:  R Vater; M J Cullen; J B Harris
Journal:  Histochem J       Date:  1994-12

8.  Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy.

Authors:  Robert J Osborne; Xiaoyan Lin; Stephen Welle; Krzysztof Sobczak; Jason R O'Rourke; Maurice S Swanson; Charles A Thornton
Journal:  Hum Mol Genet       Date:  2009-02-17       Impact factor: 6.150

9.  Microtubule-associated protein tau epitopes are present in fiber lesions in diverse muscle disorders.

Authors:  U Lübke; J Six; M Villanova; J Boons; M Vandermeeren; C Ceuterick; P Cras; J J Martin
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

10.  Porcine bladder urothelial, myofibroblast, and detrusor muscle cells: characterization and ATP release.

Authors:  Ying Cheng; Kylie J Mansfield; Shaun L Sandow; Prajni Sadananda; Elizabeth Burcher; Kate H Moore
Journal:  Front Pharmacol       Date:  2011-06-07       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.